carbonyl cyanide m-chlorophenyl hydrazone has been researched along with Neuroendocrine Tumors in 2 studies
Carbonyl Cyanide m-Chlorophenyl Hydrazone: A proton ionophore. It is commonly used as an uncoupling agent and inhibitor of photosynthesis because of its effects on mitochondrial and chloroplast membranes.
CCCP : A member of the class of monochlorobenzenes that is benzene substituted by 2-(1,3-dinitrilopropan-2-ylidene)hydrazinyl and chloro groups at positions 1 and 3, respectively. It is a mitochondrial depolarizing agent that induces reactive oxygen species mediated cell death.
Neuroendocrine Tumors: Tumors whose cells possess secretory granules and originate from the neuroectoderm, i.e., the cells of the ectoblast or epiblast that program the neuroendocrine system. Common properties across most neuroendocrine tumors include ectopic hormone production (often via APUD CELLS), the presence of tumor-associated antigens, and isozyme composition.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Data from pNETs reported to the National Cancer Database between 2004 and 2016 were examined." | 1.72 | Pancreatic Neuroendocrine Tumors: The Effect of Facility Type on Patient Survival. ( Alvarado, LA; Elhanafi, S; Joseph, S; Konstantinidis, IT; Lee, S; Maegawa, FB; Mendoza-Ladd, A; Philipovskiy, A; Tyroch, AH, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, S | 1 |
| Maegawa, FB | 1 |
| Joseph, S | 1 |
| Alvarado, LA | 1 |
| Mendoza-Ladd, A | 1 |
| Elhanafi, S | 1 |
| Philipovskiy, A | 1 |
| Tyroch, AH | 1 |
| Konstantinidis, IT | 1 |
| Platoff, RM | 1 |
| Lou, J | 1 |
| Bush, K | 1 |
| Zhu, C | 1 |
| Spitz, E | 1 |
| Gaughan, JP | 1 |
| Atabek, U | 1 |
| Spitz, F | 1 |
| Hong, YK | 1 |
2 other studies available for carbonyl cyanide m-chlorophenyl hydrazone and Neuroendocrine Tumors
| Article | Year |
|---|---|
Pancreatic Neuroendocrine Tumors: The Effect of Facility Type on Patient Survival.
Topics: Carbonyl Cyanide m-Chlorophenyl Hydrazone; Health Facilities; Humans; Neuroectodermal Tumors, Primit | 2022 |
Gastric Neuroendocrine Tumor Treatment and Survival Outcome Depends on Facility Type.
Topics: Carbonyl Cyanide m-Chlorophenyl Hydrazone; Hospitals; Humans; Neuroendocrine Tumors; Pancreatic Neop | 2023 |